Preventive Care
Conference Coverage
CDC: Trivalent adjuvanted influenza vaccine aIIV3 safe in elderly adults
ATLANTA – Postlicensure surveillance shows no new or unexpected adverse events with aIIV3 (FLUAD).
Conference Coverage
Breast cancer risk in type 2 diabetes related to adiposity
Women with type 2 diabetes mellitus have a moderately increased risk of breast cancer that appears to be mainly caused by adiposity, not diabetes...
Conference Coverage
Zoledronate reduces fracture risk in elderly women with osteopenia
Women with osteopenia who received intravenous zoledronate had a significantly lower risk of fractures.
Guidelines
Guideline: Early screening warranted if family history of nonhereditary colorectal cancer
Initial screening colonoscopy should occur at age 40-50 years, or 10 years before the age of the earliest-diagnosed first-degree relative.
From the Journals
Swings in four metabolic measures predicted death in healthy people
Risk for death is higher in people with swings in fasting blood glucose and cholesterol levels, systolic blood pressure, and body mass index.
From the Journals
ASPREE: What to do now about aspirin for healthy elderly people
While low-risk people don’t benefit, patients who are at mid to high cardiovascular risk clearly might.
Video
Get on top of home BP monitoring now
CHICAGO – The devices are good, available, and inexpensive, so what’s the holdup?
From the Journals
Online diabetes prevention programs as good as face-to-face programs
An intensive, multifaceted online DPP intervention may be as effective as in-person DPP and help expand reach to those at risk.
From the Journals
Cirrhosis study finds no link between screening, liver cancer mortality
Among patients with cirrhosis, screening for hepatocellular carcinoma was not associated with reductions in liver cancer mortality.
From the Journals
Commentary: Composite risk, not age, is key for timing first colorectal cancer screening
Age may not be the colorectal cancer screening issue.
Latest News
NELSON trial: CT Screening reduces lung cancer deaths
The NELSON trial is the second large-scale trial to show that screening significantly reduces lung cancer mortality.